NP / PA
Fullerton, Erica
Fullerton, Erica was paid $711K by Medicaid between Jan 2018 and Nov 2024, across 26 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 26% of everything it billed.
33Billing provider infoFULLERTON, ERICA
WORCESTER, MA 01605
WORCESTER, MA 01605
33aNPI1255379020assigned 06/03/2006
33bProvider typeAdvanced Practice Midwife
28Total paid$711K
24GClaims12,472
24DCodes billed26
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Advanced Practice Midwife providers in Massachusetts
Rank by total paid#1 of 22
Median peer was paid$0.00
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,251 | $101K | |
| 2019 | 732 | $48K | |
| 2020 | 1,776 | $94K | |
| 2021 | 2,788 | $168K | |
| 2022 | 2,504 | $143K | |
| 2023 | 1,476 | $95K | |
| 2024incomplete | 945 | $63K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 26% | 1,640 | 1,547 | $186K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 19% | 1,625 | 1,533 | $137K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 2,767 | 2,401 | $120K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 13% | 1,097 | 1,069 | $91K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 7.2% | 859 | 839 | $51K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.1% | 541 | 531 | $29K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3.8% | 309 | 300 | $27K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 1,336 | 1,180 | $18K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.7% | 213 | 205 | $12K |
| 86780 | 1.1% | 242 | 228 | $8K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.1% | 114 | 114 | $7K |
| 81025 | <1% | 818 | 766 | $4K |
14 more codes
| 86803 | <1% | 54 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 140 | $3K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 48 | $3K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 17 | $2K |
| 87340 | <1% | 54 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 201 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 75 | $2K |
| 99442 | <1% | 49 | $1K | |
| 85027 | <1% | 30 | $864.43 | |
| 86701 | <1% | 127 | $853.32 | |
| 81001 | <1% | 67 | $739.83 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 25 | $523.51 |
| 87210 | <1% | 12 | $38.32 | |
| 87220 | <1% | 12 | $38.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.